Skip to Main Content
Menu Button
About Us
Our Team
Careers
Technology
Clinical Pipeline
News
Contact
2019
Brand Icon
GLP pharmacokinetic (PK) and toxicology studies were completed at Charles River Laboratories, confirming the favorable safety profile of QQ-SON.
Recent news & press
2026
Prof Wang was invited to attend Tigermed's ASCO Pre-Event Webinar as a Speaker to introduce...
Learn More
Apr. 2026
no infusion related reaction (IRR) has occurred during the 48-hour continuous infusion by pump, this...
Learn More